amonafide has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckner, JC; Burch, PA; Cascino, TL; Gallagher, JG; Goldberg, RM; Levitt, R; Morton, RF; O'Fallon, JR; Scheithauer, BW; Westberg, MW | 1 |
| Comis, RL; Nash, SL; O'Dwyer, PJ; Ozols, RF; Perez, RP | 1 |
| Bonnet, JD; Braun, TJ; Crowley, J; Hanson, KH; Keppen, M; Salmon, SE | 1 |
3 trial(s) available for amonafide and Recrudescence
| Article | Year |
|---|---|
Phase II study of amonafide in patients with recurrent glioma.
Topics: Adenine; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Nervous System Diseases; Oligodendroglioma; Organophosphonates; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 1995 |
Phase II study of amonafide in advanced and recurrent sarcoma patients.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imides; Injections, Intravenous; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Recurrence; Sarcoma; Treatment Outcome | 1992 |
Evaluation of amonafide in refractory and relapsing multiple myeloma: a Southwest Oncology Group study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Blood Cell Count; Drug Resistance; Female; Granulocytes; Humans; Imides; Isoquinolines; Leukopenia; Male; Middle Aged; Multiple Myeloma; Naphthalimides; Organophosphonates; Recurrence; Thrombocytopenia | 1991 |